Skip to main content

Advertisement

Log in

Triple Point-Mutants of Hypoxia-Inducible Factor-1α Accelerate In Vivo Angiogenesis in Bone Defect Regions

  • Original Paper
  • Published:
Cell Biochemistry and Biophysics Aims and scope Submit manuscript

Abstract

To investigate the functions of triple point-mutants of hypoxia-inducible factor 1α (HIF1α) in angiogenesis in bone defect regions under normoxic conditions. 1. Triple point-mutations (in amino acids 402, 564, and 803) in the HIF1α coding sequence (CDS) were induced by polymerase chain reaction. The triple mutant HIF1α (402/564/803) was inserted into the adenovirus pAdEasy-1 system for complete viral packaging and titer measurements. 2. For the in vitro experiment, rabbit bone marrow mesenchymal stem cells (MSCs) were divided into four experimental groups. The efficiency of infection was observed by the expression of human renilla reniformis green fluorescent protein (hrGFP). The HIF1α mRNA, protein and VEGF protein expression levels in infected cells in each experimental group were measured. 3. As in the in vivo experiment, the MSCs were divided into four groups and infected with the viral solutions from each complementary in vitro group and cultured under normoxic conditions. The MSCs were used as seed cells and transplanted into an apatite–wollastonite magnetic bioactive glass–ceramic (AW MGC) vector to construct artificial tissue-engineering scaffolds that were then implanted into the in vivo rabbit radial bone defect model. The animals from each group were killed 8 weeks after the surgery, and the tissues from the implantation region were harvested for the evaluation of the angiogenesis. 1. The 402,564, and 803 amino acids in CDS area were point mutated into alanine; three types of recombinant adenovirus were successfully constructed, packaged, and characterized. 2. The expression levels of HIF1α mRNA in A and B groups were significantly higher than those in the C and D groups (P < 0.05). The HIF1α and VEGF protein expression levels in A group were significantly higher than those in the other three groups (P < 0.05). 3. There was prominent angiogenesis in bone defect regions in group A animals. 1. Triple point-mutants of HIF1α efficiently expressed functional proteins under normoxic conditions. 2. Triple point-mutants HIF1α effectively promoted in vivo angiogenesis in bone defect regions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Fig. 9

Similar content being viewed by others

References

  1. Lu, C. Y., Marcucio, R., & Miclau, T. (2006). Assessing angiogenesis during fracture healing. Iowa Orthopaedic Journal, 26, 17–26.

    PubMed  Google Scholar 

  2. Seregin, S. S., & Amalfitano, A. (2009). Overcoming pre-existing adenovirus immunity by genetic engineering of adenovirus-based vectors. Expert Opinion on Biological Therapy, 9, 1521–1531.

    Article  PubMed  CAS  Google Scholar 

  3. Fiorenzo, P., Mongiardi, M. P., Dimitri, D., et al. (2010). HIF1-positive and HIF1-negative glioblastoma cells compete in vitro but cooperate in tumor growth in vivo. International Journal of Oncology, 36, 785–791.

    PubMed  CAS  Google Scholar 

  4. Giatromanolaki, A., Fiska, A., Pitsiava, D., et al. (2009). Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression. In Vivo, 23, 699–703.

    PubMed  CAS  Google Scholar 

  5. Semenza, G. L. (2007). Evaluation of HIF-1 inhibitors as anticancer agents. Drug Discovery Today, 12, 853–859.

    Article  PubMed  CAS  Google Scholar 

  6. Wan, C., Gilbert, S. R., Wang, Y., et al. (2008). Activation of the hypoxia-inducible factor-1-alpha pathway accelerates. Proceedings of the National Academy of Sciences, 105, 686–691.

    Article  CAS  Google Scholar 

  7. Wang, Y., Wan, C., Deng, L., et al. (2007). The hypoxia-inducible factor 1 alpha pathway couples angiogenesis to osteogenesis during skeletal development. The Journal of Clinical Investigation, 117, 1616–1626.

    Article  PubMed  CAS  Google Scholar 

  8. Khan, T. A., Sellke, F. W., & Laham, R. J. (2003). Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Therapy, 10, 285–291.

    Article  PubMed  CAS  Google Scholar 

  9. Giaccia, A., Siim, B. G., & Johnson, R. S. (2003). HIF-1 as a target for drug development. Nature Reviews Drug Discovery, 2, 803–811.

    Article  PubMed  CAS  Google Scholar 

  10. Ceradini, D. J., Yao, D., Grogan, R. H., et al. (2008). Decreasing intracellular superoxide corrects defective ischemia-induced new vessel formation in diabetic mice. Journal of Biological Chemistry, 283, 10930–10938.

    Article  PubMed  CAS  Google Scholar 

  11. Evans, C. E., Humphries, J., Mattock, K., et al. (2010). Hypoxia and upregulation of hypoxia- inducible factor 1{alpha} stimulate venous thrombus recanalization. Arteriosclerosis, Thrombosis, and Vascular Biology, 30, 2443–2451.

    Article  PubMed  CAS  Google Scholar 

  12. Kazi, A. A., Molitoris, K. H., & Koos, R. D. (2009). Estrogen rapidly activates the PI3 K/AKT pathway and hypoxia-inducible factor 1 and induces vascular endothelial growth factor A expression in luminal epithelial cells of the rat uterus. Biology of Reproduction, 81, 378–387.

    Article  PubMed  CAS  Google Scholar 

  13. Bruick, R. K., & McKnight, S. L. (2001). A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337–1340.

    Article  PubMed  CAS  Google Scholar 

  14. Szuromi, P. (2001). The enzymology of oxygen sensing. Science, 294, 1239.

    Google Scholar 

  15. Lando, D., Peet, D. J., Whelan, D. A., et al. (2002). Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch. Science, 295, 858–861.

    Article  PubMed  CAS  Google Scholar 

  16. Lim, W., Cho, J., Kwon, H. Y., et al. (2009). Hypoxia-inducible factor 1 alpha activates and is inhibited by unoccupied estrogen receptor beta. FEBS Letters, 583, 1314–1318.

    Article  PubMed  CAS  Google Scholar 

  17. Emans, P. J., Spaapen, F., Surtel, D. A., et al. (2007). A novel in vivo model to study endochondral bone formation; HIF-1α activation and BMP expression. Bone, 40, 409–418.

    Article  PubMed  CAS  Google Scholar 

  18. Simon, F., Bockhorn, M., Praha, C., et al. (2010). Deregulation of HIF1-alpha and hypoxia- regulated pathways in hepatocellular carcinoma and corresponding non-malignant liver tissue–influence of a modulated host stroma on the prognosis of HCC. Langenbeck’s Archives of Surgery, 395, 395–405.

    Article  PubMed  Google Scholar 

  19. Elson, D. A., Thurston, G., Huang, L. E., et al. (2001). Induction of hypervascularity without leakage or inflammation in transgenic mice overexpressing hypoxia-inducible factor-1alpha. Genes & Development, 15, 2520–2532.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This project is funded by the Liaoning Affiliated Hospital Youth Science and Technology Startup Fund (FY2012-04).

Conflict of interest

The authors declare that they have no competing interests.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Danping Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, C., Liu, D., Zhang, Z. et al. Triple Point-Mutants of Hypoxia-Inducible Factor-1α Accelerate In Vivo Angiogenesis in Bone Defect Regions. Cell Biochem Biophys 67, 557–566 (2013). https://doi.org/10.1007/s12013-013-9541-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12013-013-9541-8

Keywords

Navigation